BIO member Hamamatsu Pharma Research available for 1-on-1 partnering sessions.

HPR announces publication of a brain imaging study in a NHP model of unilateral neuropathy.

Neuroprotective effect of brimonidine in a NHP model of ocular hypertension.

HPR is virtually attending Korea Pharm & Bio 2021, May 25 - 28. Looking forward to presenting HPR's services!

Press release “HPR, a preclinical CRO specializing in pharmacological evaluation of novel therapeutics in nonhuman primate disease...

HPR is attending Bio Japan 2020 in Yokohama Oct 14 - 16. Looking forward to having great meetings there!

HPR is attending BIO-Europe Fall 2020

HPR is attending BioPharm America

Even though it's a virtual conference, HPR is looking forward to attending BIO!

Bio-Europe Spring 2020 will be digitally held between March 23 - 27! HPR is open to all meeting requests!

Announcing Astrocyte Pharmaceuticals' efficacy study of AST-004 in a NHP model of stroke! For more details, click here

HPR is attending BIO Europe Spring in March 23 - 25. Please check our booth in Japan Pavilion #112.

HPR is looking forward to presenting our stroke model at this International Stroke Conference!

HPR's first paper about a macaque model of ulcerative colitis in 2020 is now open to everyone! Click and check the paper

HPR is attending and presenting a poster at a pain conference in Keystone, Colorado, Feb 2 - 5, 2020. We are looking forward to...

Our latest paper about functional neuroimaging with pain is available now! For more details, check the following site.

Research collaboration project, “Transmission-blocking Vaccine of Malaria”, has been accepted by the Global Health Innovative Technology...